RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 42 filers reported holding RAIN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $777,916 | -28.4% | 902,664 | -0.3% | 0.00% | – |
| Q2 2023 | $1,086,205 | -85.9% | 905,171 | +2.7% | 0.00% | – |
| Q1 2023 | $7,700,727 | +112.5% | 881,090 | +94.5% | 0.00% | – |
| Q4 2022 | $3,624,208 | +69.6% | 453,026 | +3.5% | 0.00% | – |
| Q3 2022 | $2,137,000 | -12.2% | 437,746 | 0.0% | 0.00% | – |
| Q2 2022 | $2,434,000 | -7.8% | 437,746 | -16.0% | 0.00% | – |
| Q1 2022 | $2,641,000 | -59.6% | 521,033 | +2.7% | 0.00% | – |
| Q4 2021 | $6,534,000 | +11.8% | 507,275 | +29.9% | 0.00% | – |
| Q3 2021 | $5,843,000 | +3.2% | 390,544 | +7.2% | 0.00% | – |
| Q2 2021 | $5,661,000 | – | 364,328 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,560,652 | $7,616,000 | 1.78% |
| Cormorant Asset Management, LP | 2,326,660 | $11,354,000 | 0.79% |
| BVF INC/IL | 3,526,729 | $17,210,000 | 0.71% |
| Perceptive Advisors | 2,483,619 | $12,120,000 | 0.35% |
| Boxer Capital, LLC | 1,175,000 | $5,734,000 | 0.32% |
| UBS OCONNOR LLC | 326,451 | $1,593,000,000 | 0.03% |
| Ergoteles LLC | 65,096 | $318,000 | 0.01% |
| Lumina Fund Management LLC | 6,000 | $29,000 | 0.01% |
| Laurion Capital Management LP | 313,200 | $1,528,000 | 0.01% |
| Woodline Partners LP | 119,700 | $584,000 | 0.01% |